期刊文献+

Jo-1综合征的临床及骨骼肌病理特点 被引量:3

Clinical and myopathological features of Jo-1 syndrome
原文传递
导出
摘要 目的 报道16例Jo-1综合征患者的临床和骨骼肌病理改变特点.方法 本研究选取2011年1月至2015年7月于北京大学第一医院神经内科诊断为Jo-1综合征的16例患者,对其临床资料及肌肉病理资料进行分析.结果 16例患者的平均起病年龄为41±14(21 ~68)岁,女性占87.5%,病程中位数为9.5(1 ~192)个月.主要临床表现包括13例肌无力(81.2%)、10例关节炎(62.5%)、8例间质性肺病(50%)、5例皮肌炎样皮疹(31.2%)、3例发热(18.8%)、2例雷诺现象(12.5%)、2例技工手(12.5%),3例合并其他结缔组织病和1例合并非霍奇金淋巴瘤.血清平均CK为3 054±2 058(470 ~5 222)U/L.所有患者抗Jo-1抗体阳性,合并出现的抗体包括1例抗Mi-2抗体、5例抗Ro-52抗体、5例抗核抗体.4/5例患者行肌电图检查呈肌源性损害特点.肌肉病理表现包括14例(87.5%)肌束衣水肿、断裂、炎细胞浸润.13例萎缩肌纤维,其中7例(43.8%)主要位于束周区域.8例肌纤维坏死,其中4例(25%)主要位于束周区域.11例出现再生肌纤维,其中5例(31.2%)主要位于束周区域.CD8阳性的T-淋巴细胞、CD20阳性的B-淋巴细胞、CD68阳性的巨噬细胞不同程度浸润,多数位于肌束衣.MHC-Ⅰ在肌纤维膜不同程度表达,其中7例(43.8%)束周肌纤维胞质阳性表达.7例(43.8%)束周肌纤维膜补体沉积,2例(12.5%)束周毛细血管补体沉积.结论 本组Jo-1综合征患者的主要表现是肌无力、关节炎和间质性肺病,可以合并皮肌炎样皮疹、发热、雷诺现象、技工手.肌束衣水肿、断裂伴随炎细胞浸润常见.部分患者可出现束周肌纤维病变. Objective To report the clinical and myopathological features of 16 patients with Jo-1 syndrome.Methods Sixteen patients were recruited in this study,who were diagnosed as Jo-1 syndrome in Department of Neurology of Peking University First Hospital from January,2011 to July,2015.The clinical data and myopathological data were analyzed.Results The mean onset age was 41-± 14 (21-68) years old.87.5% was female.The median duration was 9.5 months (1-192 months).The main clinical manifestations were weakness in 13 cases (81.2%),arthritis in 10 cases (62.5%),interstitial lung diseases in 8 cases (50%),dermatomyositis-like skin lesions in 5 cases (31.2%),fever in 3 cases (18.8%),Raynaud's phenomenon in 2 cases (12.5%) and mechanic's hands in 2 cases (12.5%).There were 3 cases with other connective tissue diseases and 1 case with non-Hodgkin's lymphoma.Mean serum CK was 3 054 ± 2 058 (470-5 222) U/L.All patients had anti-Jo-1 antibody,combined with anti Mi-2 antibody in 1 case,anti-Ro-52 antibody in 5 cases,and anti-nuclear antibody in 5 cases.4/5 cases showed myopathic changes for electromyography (EMG) tests.Myopathological changes included edema,fragmentation and inflammatory infiltration in perimysium in 14 cases (87.5%),muscle atrophy in 13 cases including 7 cases(43.8%) predominantly in perifascicular field.Muscle fiber necrosis appeared in 8 cases with predominantly in perifascicular area in 4 cases (25%).Muscle fiber regeneration occurred in 11 cases with predominantly in perifascicular field in 5 cases (31.2%).CD8 positive T-lymphocytes,CD20 positive B-lymphocytes and CD68 positive macrophages infiltrated in various degrees,most of which were located in perimysium.MHC-Ⅰ were expressed on muscle fiber membranes in different degrees,including 7 cases (43.8%) predominantly in the cytoplasm of perifascicular muscle fibers.C5b-9 deposited in perifascicular muscle fiber membranes in 7 cases (43.8%) and perifascicular capillaries in 2 cases (12.5%).Conclusions The main manifestations of this group of Jo-1 syndrome are weakness,arthritis and interstitial lung diseases,and dermatomyositis-like skin lesions,fever,Raynaud's phenomenon,and mechanic's hands can also be seen.Edema,fragmentation and inflammatory infiltration in perimysium are common.Pathological changes in perifascicular fields appear in some cases.
出处 《中华医学杂志》 CAS CSCD 北大核心 2016年第29期2352-2355,共4页 National Medical Journal of China
关键词 肌疾病 Jo-1综合征 骨骼肌病理 Muscular diseases Jo-1 syndrome Myopathology
  • 相关文献

参考文献21

  • 1Tansley SL, McHugh NJ. Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies [ J ]. Curr Rbeamatol Rep, 2014, 16 (12) :464. DOI : 10. 1007/s11926-014-0464-1.
  • 2Hamaguchi Y, Fujimoto M, Matsushita T, et al. Common and distinct clinical features in adult patients with anti-aminoacyl- tRNA synthetase antibodies: heterogeneity within the syndrome [J]. PLoS One, 2013, 8(4):e60442. DOI :10. 1371/journal. pone. 0060442.
  • 3Watkins J, Farzaneh-Far R, Tahir H, et al. Jo-1 syndrome with associated poorly differentiated adenocarcinoma [ J ]. Rhcumatology (Oxford), 2004, 43 (3) :389-390. DOI :10. 1093/rheumatology/ keg473.
  • 4Vancsa A, Csipo I, Nameth J, et al. Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients[J]. Rheumatol Int, 2009, 29(9):989-994. DOI :10. 1007/s00296 -009 -0884 -9.
  • 5Shinjo SK, Levy-Nero M. Anti-Jo-1 antisynthetase syndrome[ J]. Rev Bras Reumatol, 2010, 50(5) :492-500.
  • 6Stanciu R, Guiguet M, Musset L, et al. Antisynthetase syndrome with anti-Jol antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use [ J ]. J Rheumatol, 2012, 39 (9) : 1835-1839. DOI : 10. 3899/jrheum. 111604.
  • 7Mescam-Mancini L, Allenbach Y, Hervier B, et al. Anti-Jo-I antibody-positive patients show a characteristic necmtizing perifascicular myositis[ J]. Brain, 2015, 138 (Pt 9 ) : 2485-2492.DOI :10. 1093/brain/awv192.
  • 8Mozaffar T, Pestronk A. Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres [ J ]. J Neural Neurosurg Psychiatry, 2000, 68 (4) :472-478.
  • 9Stenzel W, PreulSe C, Allenbach Y, et al. Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy [ J ]. Neurology, 2015,84 ( 13 ) : 1346-1354. DOI : 10. 1212/WNL. 0000000000001422.
  • 10张丽君,叶志中,庄俊汉,李博,李剑松,汪迅,钟力,罗秀霞.抗Jo-1抗体在多发性肌炎/皮肌炎中的临床研究[J].中华风湿病学杂志,2004,8(3):165-167. 被引量:21

二级参考文献20

  • 1Richards TJ, Eggebeen A, Gibson K, et al. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody- positive interstitial lung disease. Arthritis Rheum, 2009, 60: 2183-2192.
  • 2Stone KB, Oddis CV, Fertig N,et al.Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopa- thy. Arthritis Rheum, 2007,56: 3125-3131.
  • 3Isenberg DA, Allen E, Farewell V, et al. International consen- sds outcome measures for patients with idiopathic inflammatory myopathies: development and initial validation of myositis activi- ty and damage indices in patients with adult onset disease. Rheumatology (Oxford), 2004, 43 : 49-54.
  • 4Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med, 1991, 325: 1487-1498.
  • 5Targoff IN, Miller EW, Medsger TA Jr, et al. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol, 1997, 9: 527-535.
  • 6Sibilia J, Chatelus E, Meyer A, et al. How can we diagnose and better understand inflammatory myopathies: the usefulness of auto-antibodies. Presse Med, 2010, 39: 1010-1025.
  • 7Troyanov Y,Targoff IN,Tremblay JL,et al.Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies:analysis of 100 French Canadian patients[J].Medicine (Baltimore),2005,84(4):231-249.
  • 8Ghirardello A,Zampieri S,Tarricone E,et al.Clinical implications of autoantibody screening in patients with autoimmune myositis[J].Autoimmunity,2006,39(3):217-221.
  • 9Sordet C,Goetz J,Sibilia J.Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease[J].Joint Bone Spine,2006,73(6):646-654.
  • 10Mielnik P,Wiesik-Szewczyk E,Olesinska M,et al.Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies[J].Autoimmunity,2006,39(3):243-247.

共引文献27

同被引文献7

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部